Wiley Interdisciplinary Reviews-RNA

Papers
(The H4-Index of Wiley Interdisciplinary Reviews-RNA is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-07-01 to 2024-07-01.)
ArticleCitations
Dynamic transcriptomic m5C and its regulatory role in RNA processing119
microRNA strand selection: Unwinding the rules112
Regulation of ribosomal protein genes: An ordered anarchy77
Circular RNA translation, a path to hidden proteome74
The role of RNA editing enzyme ADAR1 in human disease71
microRNA‐based diagnostic and therapeutic applications in cancer medicine61
Ribosome heterogeneity and specialization in development56
RNA methyltransferase METTL16: Targets and function49
Therapeutic promise of engineered nonsense suppressor tRNAs43
Ribosome dynamics and mRNA turnover, a complex relationship under constant cellular scrutiny43
RNA nucleotide methylation: 2021 update43
Artificial miRNAs as therapeutic tools: Challenges and opportunities41
RNA structures in alternative splicing and back‐splicing39
A birds'‐eye view of the activity and specificity of the mRNA m6A methyltransferase complex37
Biogenesis, characterization, and functions of mirtrons36
Intron retention and its impact on gene expression and protein diversity: A review and a practical guide35
On the function and relevance of alternative 3′‐UTRs in gene expression regulation35
Evolutionary conservation of RNA sequence and structure35
The multifaceted eukaryotic cap structure34
Functions and mechanisms of RNA tailing by metazoan terminal nucleotidyltransferases32
The multifaceted role of PARP1 in RNA biogenesis31
Applications of the versatile CRISPR‐Cas13 RNA targeting system27
Splicing alterations in healthy aging and disease27
Regulation of antiviral innate immunity by chemical modification of viral RNA26
Deep structural insights into RNA‐binding disordered protein regions26
A mechanistic view of long noncoding RNAs in cancer26
The many facets of miR‐223 in cancer: Oncosuppressor, oncogenic driver, therapeutic target, and biomarker of response26
0.34317302703857